Somedeb Ball

12PUBLICATIONS
52CO-AUTHORS
Haematological tumoursMedical molecular engineering of nucleic acids and proteinsTime-series analysisCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 27, 2026
Chronic myelomonocytic leukemia beyond the marrow: biology, patterns, and management of extramedullary disease.

|Feb 11, 2026
Prognostic Model Combining Mutational and Cytogenetic Profiles in Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents.

Dimitrios Drekolias, Fatima Tuz Zahra, Caroline Fileni

|Feb 04, 2026
Global Epidemiologic Trends of Early-Onset Cancers From 1990 to 2021 and Projection to 2040.

Rupayan Kundu, Ankush Mukhopadhyay, Niladri Kal

|Aug 07, 2025
Hypomethylating Agent and Venetoclax Combination Is a Safe and Effective Alternative to Intensive Chemotherapy in Older (≥ 70 Years) Patients With Newly Diagnosed Favorable Risk Acute Myeloid Leukemia.

Somedeb Ball, Akriti G Jain, Najla Al Ali

|Oct 16, 2024
Complete remission in a case of acute undifferentiated leukemia with novel combination therapy of FLAG-IDA and venetoclax.

Roma A Kankaria, Jeremy B Jones, Michael Zargari

|May 05, 2023
Assessment and validation of the molecular international prognostic scoring system for myelodysplastic syndromes.

Luis E Aguirre, Najla Al Ali, David A Sallman

Pageof 2

Frequent Collaborators

5 joint publications

Rami S Komrokji

4 joint publications

David A Sallman

4 joint publications

Jeffrey Lancet

4 joint publications

Andrew T Kuykendall